Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 00:28:36 UTC 2023
by
admin
on
Sat Dec 16 00:28:36 UTC 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
F7R0FBC1XD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
4484
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
||
|
NDF-RT |
N0000184169
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
||
|
WHO-VATC |
QB02BD07
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
||
|
WHO-ATC |
B02BD07
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
N0000175979
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | Increased Coagulation Activity [PE] | ||
|
100000124487
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
SUB13818MIG
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
N0000168159
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | Transglutaminases [Chemical/Ingredient] | ||
|
1091605
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
D005176
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
C200601
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
F7R0FBC1XD
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
9013-56-3
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
4271
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
ALTERNATIVE | RxNorm | ||
|
m5237
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
F7R0FBC1XD
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
N0000007914
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | Blood Coagulation Factors [Chemical/Ingredient] | ||
|
N0000184155
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | Increased Fibrin Polymerization Activity [PE] | ||
|
DB12909
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY |
From | To |
---|---|
3_5 | 3_56 |
3_39 | 3_67 |
3_71 | 3_115 |
3_98 | 3_126 |
3_133 | 3_177 |
3_160 | 3_188 |
3_193 | 3_235 |
3_221 | 3_247 |
3_254 | 3_296 |
3_282 | 3_307 |
3_316 | 3_358 |
3_344 | 3_369 |
3_376 | 3_419 |
3_405 | 3_430 |
3_434 | 3_485 |
3_466 | 3_495 |
3_504 | 3_547 |
3_533 | 3_558 |
3_562 | 3_616 |
3_596 | 3_626 |
4_5 | 4_56 |
4_39 | 4_67 |
4_71 | 4_115 |
4_98 | 4_126 |
4_133 | 4_177 |
4_160 | 4_188 |
4_193 | 4_235 |
4_221 | 4_247 |
4_254 | 4_296 |
4_282 | 4_307 |
4_316 | 4_358 |
4_344 | 4_369 |
4_376 | 4_419 |
4_405 | 4_430 |
4_434 | 4_485 |
4_466 | 4_495 |
4_504 | 4_547 |
4_533 | 4_558 |
4_562 | 4_616 |
4_596 | 4_626 |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
N | 1_613 |
N | 2_613 |
N | 3_142 |
N | 3_525 |
N | 4_142 |
N | 4_525 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:CENTRIFUGATION | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|